Free Trial

BioAtla (BCAB) Insider Trading & Ownership

+0.09 (+6.34%)
(As of 06/21/2024 ET)

BioAtla (NASDAQ:BCAB) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Amount Of
Insider Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Get BCAB Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioAtla stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCAB Insider Buying and Selling by Quarter

BioAtla Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/26/2023Sylvia McbrinnDirectorBuy4,000$2.33$9,320.00  
12/20/2023Jay M Phd ShortCEOBuy50,000$2.14$107,000.00  
12/19/2023Lawrence SteinmanDirectorBuy20,000$2.05$41,000.00  
9/8/2023Sylvia McbrinnDirectorBuy2,000$2.54$5,080.00  
(Data available from 1/1/2013 forward)

BCAB Insider Trading Activity - Frequently Asked Questions

Who is on BioAtla's Insider Roster?
What percentage of BioAtla stock is owned by insiders?

11.50% of BioAtla stock is owned by insiders. Learn more on BCAB's insider holdings.

Which BioAtla insiders have been buying company stock?

The following insiders have purchased BCAB shares in the last 24 months: Christian Vasquez ($48,000.00), Jay M Phd Short ($414,360.00), Lawrence Steinman ($41,000.00), and Sylvia Mcbrinn ($79,461.00).

How much insider buying is happening at BioAtla?

Insiders have purchased a total of 170,850 BCAB shares in the last 24 months for a total of $582,821.00 bought.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:BCAB) was last updated on 6/23/2024 by Staff

From Our Partners